Table 1 Clinical characteristic of the patients with juvenile idiopathic arthritis
Sex | Age | JIA subtype | Disease duration (years) | No. of active joints | CRP levels * (mg/dL) | Treatment duration with etanercept (years) | Etanercept dosage (mg*1/w) | |
|---|---|---|---|---|---|---|---|---|
1 | F | 16 | Psoriatic arthritis | 3 | 0 | 3.6 | 0.7 | 50 |
2 | F | 16 | Oligoarthritis | 4 | 0 | < 0.5 | 3 | 50 |
3 | M | 10 | Polyarthritis | 9 | 0 | 4.5 | 0.8 | 25 |
4 | F | 21 | Oligoarthritis | 18 | 3 | n/a | 10 | 50 |
5 | M | 8 | Polyarthritis | 3 | 1 | 5.5 | 3 | 25 |
6 | F | 15 | Polyarthritis | 7 | 0 | 8.6 | 6 | 50 |
7 | F | 18 | Oligoarthritis | 15 | 0 | n/a | 5 | 50 |
8 | M | 5 | Systemic | 4 | 0 | < 0.5 | 3 | 25 |
9 | F | 15 | Polyarthritis | 4 | 0 | 10.1 | 3 | 50 |
10 | F | 15 | Psoriatic arthritis | 6 | 1 | < 0.5 | 1 | 50 |
11 | F | 3 | Polyarthritis | 2 | 0 | < 0.5 | 0.6 | 7.5 |